Tumor genome sequencing shows the most frequently altered gene in bladder cancer: Telomerase reverse transcriptase
Monday, April 20, 2015 - 09:00
in Health & Medicine
Researchers have reported that the telomerase reverse transcriptase gene promoter was altered in 69 percent of 54 cases of bladder cancer. Telomerase reverse transcriptase alterations frequently co-occur with alterations in recently identified bladder cancer genes such as STAG2 and KDM6A.